Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients
JACC: Cardiovascular Interventions · 2024-04 · 17 (8) · 979-988
DOI: 10.1016/j.jcin.2024.02.014 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2024-04. Verfasst von Neal S Kleiman und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA. Electronic address: nkleiman@houst…. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Quality of Life, Transcatheter Aortic Valve Replacement, Health Status. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Medtronic Inc.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Interventional Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA. Electronic address: nkleiman@houstonmethodist.org.
- Thoraxcenter, Erasmus University, Rotterdam, the Netherlands.
- Department of Cardiothoracic Surgery, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA.
- Department of Interventional Cardiology, University of Pittsburgh Medical Center Pinnacle, Wormleysburg, Pennsylvania, USA.
- Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center Pinnacle Health, Harrisburg, Pennsylvania, USA.
- Department of Cardiothoracic Surgery, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Förderung
- Medtronic Inc
Zitieren
APA
Kleiman, N. S., Van Mieghem, N. M., Reardon, M. J., Gada, H., Mumtaz, M., Olsen, P. S., Heiser, J., Merhi, W., Chetcuti, S., Deeb, G. M., Chawla, A., Kiaii, B., Teefy, P., Chu, M. W. A., Yakubov, S. J., Windecker, S., Althouse, A. D., & Baron, S. J. (2024). Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients. JACC: Cardiovascular Interventions, 17(8), 979-988. https://doi.org/10.1016/j.jcin.2024.02.014
Vancouver
Kleiman NS, Van Mieghem NM, Reardon MJ, Gada H, Mumtaz M, Olsen PS, et al. Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients. JACC: Cardiovascular Interventions. 2024;17(8):979-988. doi:10.1016/j.jcin.2024.02.014
BibTeX
@article{Kleiman2024,
author = {Kleiman, Neal S and Van Mieghem, Nicolas M and Reardon, Michael J and Gada, Hemal and Mumtaz, Mubashir and Olsen, Peter Skov and Heiser, John and Merhi, William and Chetcuti, Stanley and Deeb, G Michael and Chawla, Atul and Kiaii, Bob and Teefy, Patrick and Chu, Michael W A and Yakubov, Steven J and Windecker, Stephan and Althouse, Andrew D and Baron, Suzanne J},
title = {Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients},
journal = {JACC: Cardiovascular Interventions},
year = {2024},
volume = {17},
number = {8},
pages = {979--988},
doi = {10.1016/j.jcin.2024.02.014}
}
EUVIMED